Not recruiting
Liver transplant rejection
Not recruitingInvestigationalNo placebo
Study of QEL-001 (CAR T regulatory cell therapy) to prevent liver transplant rejection in patients with HLA-A2 positive donor organ
InvestigationalNo placebo
- Disease:Liver transplant rejection
- Substances:Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Autologous T Regulatory Cells Expressing An Hla-A2-Specific Chimeric Antigen Receptor
- Sponsor:Quell Therapeutics Limited
